A Homozygous Mutation on the HBA1 Gene Coding for Hb Charlieu (HBA1: c.320T>C) Together with β-Thalassemia Trait Results in Severe Hemolytic Anemia. (4th March 2019)
- Record Type:
- Journal Article
- Title:
- A Homozygous Mutation on the HBA1 Gene Coding for Hb Charlieu (HBA1: c.320T>C) Together with β-Thalassemia Trait Results in Severe Hemolytic Anemia. (4th March 2019)
- Main Title:
- A Homozygous Mutation on the HBA1 Gene Coding for Hb Charlieu (HBA1: c.320T>C) Together with β-Thalassemia Trait Results in Severe Hemolytic Anemia
- Authors:
- Klei, Thomas R. L.
Kheradmand Kia, Sima
Veldthuis, Martijn
Dehbozorgian, Javad
Karimi, Mehran
Geissler, Judy
Sellink, Erica
Thiel-Valkhof, Marijke
Burger, Patrick
van Alphen, Floris
Meijer, Alexander B.
van Bruggen, Robin
van Zwieten, Rob - Abstract:
- Abstract: A 4-year-old boy, a β-thalassemia (β-thal) carrier, with an unexplained severe chronic microcytic anemia was referred to us. Sequencing of the α-globin genes revealed a Hb Charlieu [α106(G13)Leu→Pro, HBA1 : c.320T>C, p.Leu107Pro] mutation present on both HBA1 genes. Quantitative polymerase chain reaction (qPCR) confirmed α Charlieu mRNA in the proband and his parents, showing that the mutation does not affect mRNA stability. However, we were unable to detect the Hb Charlieu protein by capillary electrophoresis (CE), reverse phase electrophoresis, cation exchange electrophoresis or isoelectric focusing. Mass spectrometry (MS) allowed us to confirm the presence of the Hb Charlieu peptide in erythrocyte progenitors. These findings suggest that the mutation affects the stability of α Charlieu . As hemoglobin (Hb) heat stability tests showed no abnormalities in erythrocytes, we speculated that α Charlieu is already degraded during red blood cell (RBC) development. The clinical severity in the proband and the presence of new methylene blue-stained aggregates in his reticulocytes indicates that incorporation of α Charlieu destabilizes Hb. This, combined with an excess of unstable free α-globins as the result of β-thal minor, results in severely impaired erythropoiesis and, as a consequence, severe and chronic microcytic anemia in the proband.
- Is Part Of:
- Hemoglobin. Volume 43:Number 2(2019)
- Journal:
- Hemoglobin
- Issue:
- Volume 43:Number 2(2019)
- Issue Display:
- Volume 43, Issue 2 (2019)
- Year:
- 2019
- Volume:
- 43
- Issue:
- 2
- Issue Sort Value:
- 2019-0043-0002-0000
- Page Start:
- 77
- Page End:
- 82
- Publication Date:
- 2019-03-04
- Subjects:
- α-Thalassemia (α-thal) -- anemia -- β-thalassemia (β-thal) -- erythrocyte -- Hb Charlieu -- hemoglobin (Hb)
Hemoglobinopathy -- Periodicals
Hemoglobin -- Periodicals
Hematology -- Periodicals
Thalassemia -- Periodicals
Blood -- Diseases -- Periodicals
612.1111 - Journal URLs:
- http://informahealthcare.com/journal/hem ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/03630269.2019.1601107 ↗
- Languages:
- English
- ISSNs:
- 0363-0269
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4295.040000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 11021.xml